BioMap

BioMap, founded in 2020 by Robin Li and Wei Liu, is an innovative life science AI company that has developed xTrimo, the largest protein-centric large language model platform. The company's technology enables scientists to model biological processes with greater accuracy, focusing on proteins and extending to system-level interactions. By leveraging limited data, BioMap facilitates the extraction of novel insights and predictions, addressing significant challenges in protein-related drug development. With a diverse team of over 300 experts, BioMap aims to enhance the effectiveness of new drugs, ultimately striving to improve patient outcomes in the healthcare sector.